[Current aspects and trends in immunotherapy of cancer].
Boniver
J
J
Université de Liège, Service d'Anatomie et de Cytologie pathologiques.
Schaaf-Lafontaine
N
N
Moutschen
M
M
Longrée
L
L
Lovens-Degraef
D
D
Fassotte
M F
MF
Reginster
M A
MA
Simonet-Martin
M T
MT
Baudrihaye
M
M
D000920:Antibody-Dependent Cell Cytotoxicity / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000276:immunology; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D007376:Interleukin-2
Réalisations et perspectives de l'immunothérapie du cancer.